BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tavakolpour S, Mirsafaei HS, Elkaei Behjati S, Ghasemiadl M, Akhlaghdoust M, Sali S. Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy. Immunol Lett 2017;190:206-12. [PMID: 28827021 DOI: 10.1016/j.imlet.2017.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Motamedizadeh F, Alimohammadzadeh K, Hosseini SM. Monitoring and Evaluation of Program Performance and Management Control System of Tuberculosis: A Ten-Year Cross-Sectional Study in Sistan and Baluchestan Province, Iran. Shiraz E-Med J 2018;19. [DOI: 10.5812/semj.60497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
2 Yang J, Guo R, Yan D, Lu H, Zhang H, Ye P, Jin L, Diao H, Li L. Plasma Level of ADAMTS13 or IL-12 as an Indicator of HBeAg Seroconversion in Chronic Hepatitis B Patients Undergoing m-ETV Treatment. Front Cell Infect Microbiol 2020;10:335. [PMID: 32793509 DOI: 10.3389/fcimb.2020.00335] [Reference Citation Analysis]
3 Zhong S, Zhang T, Tang L, Li Y. Cytokines and Chemokines in HBV Infection. Front Mol Biosci 2021;8:805625. [PMID: 34926586 DOI: 10.3389/fmolb.2021.805625] [Reference Citation Analysis]